The Centers for Medicare & Medicaid Services (“CMS”) issued a Proposed Rule on May 26, 2023 to implement policies in the Medicaid Drug Rebate Program (“MDRP”) related to the Medicaid Services Investment and Accountability Act of 2019 (“MSIAA”) (the “Proposed Rule”). The Proposed Rule contains several provisions that are likely to have significant financial and operational implications for manufacturers participating in the MDRP. This summary is meant as a reference guide as you consider the potential impact of the Proposed Rule on your organization.
110 Riverbend Avenue, Suite 100
Powell, OH 43065
Phone: (614) 389-4004
Fax: (866) 259-4324
Email: info@twolabs.com
© Copyright 2023 | Powered by PRISM